Therapies

A landmark global framework and a new treatment option have arrived simultaneously, reshaping how Australian optometrists can diagnose and manage...

Research has found that some patients could use eye drops instead of reading glasses as they age. A retrospective study of 766...

Researchers in the US are preparing to present their findings on a “breakthrough technique” that uses electricity to mold the...

Dr Leigh Plowman discusses a key drug that tackles the symptoms of dry eye disease while he tries to understand...

A new, “first-of-its kind” presbyopia drop will soon be available in the US after the Food and Drug Administration (FDA)...

Perfuse Therapeutics, Inc., a US biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, has announced positive results from...

Rayner has released its latest Peer2Peer podcast, featuring two of Australia’s most respected ophthalmic surgeons, Dr Ben LaHood and Dr...

New data released in The Lancet Global Health by the Vision Loss Expert Group and World Health Organisation (WHO) and supported by...

Lumenis BE ANZ has announced the launch of OptiPLUS in Australia and New Zealand, which the company says is the...

At the completion of this article, the reader should be able to… •  Understand the immunomodulatory role of ciclosporin in...